United Republic of Tanzania
Tuberculosis profile
| High TB burden | High HIV burden |
Population  2012 48 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 6.1 (3.2–9.9) 13 (6.8–21)
Mortality (HIV+TB only) 7 (5.8–8) 15 (12–17)
Prevalence  (includes HIV+TB) 84 (45–140) 176 (95–283)
Incidence  (includes HIV+TB) 79 (74–84) 165 (154–175)
Incidence (HIV+TB only) 32 (30–34) 68 (64–72)
Case detection, all forms (%) 79 (75–85)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 25 241 (41) Relapse 1 062 (38)
Smear-negative 21 519 (35) Treatment after failure 154 (6)
Smear-unknown / not done 0 (0) Treatment after default 201 (7)
Extrapulmonary 14 657 (24) Other 1 363 (49)
Other 0 (0)      
Total new 61 417   Total retreatment 2 780  
           
Other (history unknown) 0        
Total new and relapse 62 479   Total cases notified 64 197  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.8 1.3 1.2
Age < 15 493 2 517 2 305
Laboratories 2012
Smear (per 100 000 population) 2.0
Culture (per 5 million population) 0.4
Drug susceptibility testing (per 5 million population) 0.1
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 88   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 88  
Retreatment 82  
TB/HIV 2012 Number (%)
TB patients with known HIV status 52 499 (82)
HIV-positive TB patients 20 269 (39)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 19 501 (96)
HIV-positive TB patients on antiretroviral therapy (ART) 10 993 (54)
HIV-positive people screened for TB 357 400  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.1 (0.3–2.8) 0 (0–5.9)
MDR-TB cases among notified pulmonary
TB cases
510 (140–1 300) 0 (0–160)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 742 (3%) 894 (32%) 1 682
Laboratory-confirmed MDR-TB cases 15 28 49
Patients started on MDR-TB treatment     44
Financing TB control 2013
National TB programme budget (US$ millions) 58
% Funded domestically 14%
% Funded internationally 19%
% Unfunded 67%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data